| Name | C-82 |
|---|
| Description | C-82 is a second-generation specific CBP/β-catenin antagonist, which inhibits the binding between β-catenin and CBP and increases the binding between β-catenin and p300. |
|---|---|
| Related Catalog | |
| Target |
CBP/β-catenin[1] |
| In Vitro | C-82 is an active form of PRI-724. C-82 inhibits the activation of isolated primary mouse quiescent hepatic stellate cells (HSCs) and promotes cell death in culture-activated HSCs[1]. |
| In Vivo | PRI-724 is phosphorylated-C-82 and is rapidly hydrolyzed to its active form C-82 in vivo, and pre-clinical studies have shown a very acceptable toxicity profile[1]. |
| Cell Assay | The culture-activated hepatic stellate cells (HSCs) are treated with or without C-82 (3, 10 μM) for 5 days. Medium change is not performed after C-82 treatment. Cell viability is examined using XTT based Cell Proliferation Kit[1]. |
| References |
| Molecular Formula | C33H34N6O4 |
|---|---|
| Molecular Weight | 578.66 |
| Storage condition | 2-8°C |